Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,961 | 32 | 75.6% |
| Travel and Lodging | $867.02 | 3 | 22.1% |
| Education | $89.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $2,443 | 10 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $457.67 | 10 | $0 (2024) |
| AbbVie Inc. | $302.59 | 6 | $0 (2023) |
| Gilead Sciences, Inc. | $242.32 | 4 | $0 (2021) |
| GENZYME CORPORATION | $139.70 | 1 | $0 (2023) |
| PFIZER PHARMACEUTICALS LLC | $125.00 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $89.00 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $76.97 | 1 | $0 (2017) |
| PBG PUERTO RICO LLC | $24.61 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $15.92 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.00 | 2 | E.R. Squibb & Sons, L.L.C. ($50.00) |
| 2023 | $235.89 | 5 | GENZYME CORPORATION ($139.70) |
| 2022 | $141.66 | 3 | E.R. Squibb & Sons, L.L.C. ($122.21) |
| 2021 | $392.85 | 8 | E.R. Squibb & Sons, L.L.C. ($214.27) |
| 2019 | $256.94 | 3 | PFIZER PHARMACEUTICALS LLC ($125.00) |
| 2018 | $123.39 | 2 | Gilead Sciences, Inc. ($101.19) |
| 2017 | $2,716 | 13 | Allergan Inc. ($2,443) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/24/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 12/06/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 08/31/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 07/05/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: Neuroscience | ||||||
| 05/25/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $139.70 | General |
| 02/27/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VIROLOGY | ||||||
| 12/07/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $101.88 | General |
| Category: Neuroscience | ||||||
| 04/21/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: VIROLOGY | ||||||
| 03/11/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Neuroscience | ||||||
| 12/15/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $112.65 | General |
| Category: Neuroscience | ||||||
| 12/07/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 09/01/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $79.12 | General |
| Category: Neuroscience | ||||||
| 08/12/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Neuroscience | ||||||
| 07/06/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $89.00 | General |
| Category: Immunology | ||||||
| 06/04/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.46 | General |
| 05/06/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: VIROLOGY | ||||||
| 04/30/2021 | PBG PUERTO RICO LLC | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, PREZCOBIX | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/04/2019 | PFIZER PHARMACEUTICALS LLC | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/21/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $116.02 | General |
| Category: Virology | ||||||
| 09/28/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 07/18/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $101.19 | General |
| Category: HCV | ||||||
| 08/17/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $100.06 | General |
| Category: HCV | ||||||
| 05/19/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $595.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 104 | 128 | $14,552 | $10,632 |
| 2022 | 3 | 91 | 117 | $10,709 | $6,916 |
| 2021 | 3 | 75 | 104 | $9,626 | $6,914 |
| 2020 | 3 | 74 | 97 | $7,565 | $5,165 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 64 | $5,816 | $4,202 | 72.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 12 | 12 | $4,611 | $3,527 | 76.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $2,370 | $1,528 | 64.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 29 | 31 | $1,756 | $1,375 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 65 | $6,003 | $4,010 | 66.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $3,426 | $1,893 | 55.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 20 | 22 | $1,281 | $1,012 | 79.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 64 | $5,937 | $4,216 | 71.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 24 | 24 | $2,738 | $1,937 | 70.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2021 | 15 | 16 | $950.40 | $760.32 | 80.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 63 | $4,813 | $3,323 | 69.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $1,647 | $964.09 | 58.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2020 | 17 | 19 | $1,105 | $878.49 | 79.5% |
About Allan Santiago
Allan Santiago is a Gastroenterology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457327306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allan Santiago has received a total of $3,917 in payments from pharmaceutical and medical device companies, with $50.00 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,961).
As a Medicare-enrolled provider, Santiago has provided services to 344 Medicare beneficiaries, totaling 446 services with total Medicare billing of $29,627. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location San Juan, PR
- Active Since 02/28/2006
- Last Updated 01/22/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457327306
Products in Payments
- ZEPOSIA (Drug) $457.67
- Epclusa (Drug) $201.25
- XELJANZ (Drug) $149.61
- Mavyret (Drug) $116.02
- Humira (Biological) $96.02
- STELARA (Biological) $89.00
- ZEPATIER (Drug) $76.97
- MAVYRET (Drug) $68.35
- XARELTO (Drug) $15.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in San Juan
Dr. Henry Gonzalez-Rivera, M.d, M.D
Gastroenterology — Payments: $39,430
Hector Lozano, Md, MD
Gastroenterology — Payments: $38,375
Dr. Rafael Rodriguez - Lopez, Md, MD
Gastroenterology — Payments: $20,525
Yahaira Moreno Denizard, M.d, M.D
Gastroenterology — Payments: $14,726
Dr. Esther Torres, M.d, M.D
Gastroenterology — Payments: $9,876
Dr. Emmanuel Reyes-Ramos, M.d, M.D
Gastroenterology — Payments: $7,845